Refine by
Lab S System Articles & Analysis
29 news found
BOC Sciences, a leading CRO in the USA, unveils its comprehensive capabilities for custom peptide drug conjugate from project design to commercial production. With its well-established conjugation platform, BOC Sciences supports pharmaceutical and biotechnology clients at the forefront of drug conjugation. Peptide-drug conjugates (PDCs) are mainly used in anti-cancer therapy, which integrates the ...
Cytokine, a subdivision of Creative Proteomics, specializes in providing cytokine research and analytical services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Recently, the product manager of the company is pleased to announce the launch of the growth factors (GF) detection service for further research enhancement. ...
BioIntelliSense, a continuous health monitoring and clinical intelligence company, today announced its acquisition of AlertWatch®, an FDA-cleared, clinically proven patient monitoring solution. AlertWatch uniquely provides robust integration, data analysis and a patented intuitive display of contextual patient data for more efficient, actionable clinical decisions. As part of the recently ...
The Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative Proteomics Cytokine recently announced the launch of the high-sensitivity Tumor Necrosis Factors (TNF) Detection Service to help with your ...
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”) a late-stage, pre-revenue diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced that Edwin “Ed” E. Rule, has joined the Company as Vice President Regulatory, Quality and Compliance. He will report ...
The E-View.AI provides leading-edge technology that dramatically reduces radiation exposure to patients and staff during endoscopic procedures. The Omega system offers several advantages that conventional fluoro systems cannot: AI automatically detects the physician’s ROI – allowing for hands-free operation Delivers the highest ...
Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative proteomics recently announced high sensitivity and wide detection range quantitative detection for systemic lupus erythematosus related cytokines ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that John Wilson has joined the company as Chief Commercial Officer. Wilson will lead the company's revenue growth for its rapid antimicrobial susceptibility testing (AST) technology as Selux prepares to commercialize its Next Generation ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that it has received a $2.8 million award from the U.S. National Institutes of Health (NIH) to help the company commercialize its Next Generation 'Phenotyping' (NGP) platform for rapid antimicrobial susceptibility testing (AST). Having ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that its Next Generation 'Phenotyping' (NGP) platform has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for positive blood culture and sterile body fluid samples. "While currently under review ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that its Next Generation 'Phenotyping' (NGP) platform has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for positive blood culture and sterile body fluid samples. "While currently under review ...
The Omega System offers several advantages that conventional fluoro systems cannot: Reduces radiation exposure to patients and staff by up to ~84% Delivers the highest level of image quality for the region of interest (ROI) while maintaining the full field of view (FOV) AI technology automatically detects the physician’s ROI – ...
The new Center, built on 120,000 square meters of land made available by the Ugandan government, is the second structure built by ANME, the African Network of Medical Excellence, a health network favored by EMERGENGY and created in 2009 to develop free health systems of excellence on the African continent. This project saw the participation of Riello UPS alongside architects from Studio ...
Thermo Fisher Scientific, the world leader in serving science, and Artificial, developers of flexible automation software, have announced a strategic technology collaboration to develop an integrated and comprehensive software automation platform for Thermo Fisher's standardized COVID-19 Testing Platform. The integration will result in increased testing throughput and support global healthcare ...
Huntsville Hospital Health System (HH Health System) and Kailos Genetics, a HudsonAlpha Resident Company, are pleased to announce a partnership to offer Assure SentinelTM testing for COVID-19 to North Alabama. Sentinel testing involves routine affordable screening of a population to identify individuals infected with the virus before they become symptomatic and is designed to ...
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that the Company has received U.S. Food and Drug Administration (FDA) clearance for a new suite of product enhancements to the Accelerate Pheno® system, which improve performance and expand the system's antimicrobial susceptibility testing (AST) menu for bloodstream infections. The new product release, formally classified as FDA ...
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today introduced a new highly automated, real-time PCR solution designed to analyze up to 6,000 samples in a single day to meet increasing global demand for COVID-19 testing. The high-throughput system enables laboratories to double or even triple their testing capacity to support global efforts to return communities ...
Selux Diagnostics, Inc., which is leading a new era in personalized medicine to treat superbug infections and combat antibiotic resistance, today announced that it has been awarded an additional $9.6 million from the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and ...
Thermo Fisher Scientific, the world leader in serving science, announced today that it has expanded its European offering of pre-validated assays for the Thermo Scientific Cascadion SM Clinical Analyzer with the addition of the CE/IVD marked Cascadion SM Immunosuppressants (ISD) Panel. Clinical laboratories can now access a complete system developed to enable simultaneous testing of cyclosporine ...
Selux Diagnostics, Inc., which is leading a new era in personalized medicine to treat multidrug resistant organism infections and combat antibiotic resistance, today announced the selection of three Selux-crafted abstracts for poster sessions at the upcoming American Society for Microbiology, ASM Microbe 2019 scientific meeting on June 20-24 in San Francisco. "Selux Diagnostics is dedicated to ...